Abbott receives FDA approval for new delivery device for Arthritis drug called Humira

ABBOTT PARK, Ill (AFX) - Abbott Laboratories said it has received US Food and Drug Administration approval for a new 'pen' delivery device for its Humira arthritis drug. Currently, Humira is taken as an injection beneath the skin via a specially designed prefilled syringe, and the company said the Humira pen is designed to be less painful and easier to use. Humira is currently indicated for moderate to severe rheumatoid arthritis and for active arthritis in patients with psoriatic arthritis, the company added. Abbott said the Humira pen will be available to US patients at the beginning of August. ... AFX News Limited / Forbes.com, June 26, 2006

Click To view Abbott Humira Pen and specifications